Published Studies Related to Amiodarone Injection
Well-designed clinical trials related to Amiodarone Injection
Effects of dronedarone started rapidly after amiodarone discontinuation. [2013]
Amiodarone significantly decreases atrial fibrillation in patients undergoing
surgery for lung cancer. [2012]
Efficacy and Safety of Celivarone, With Amiodarone as Calibrator, in Patients With an Implantable Cardioverter-Defibrillator for Prevention of Implantable Cardioverter-Defibrillator Interventions or Death: The ALPHEE Study. [2011.11.14]
Pharmacokinetics of intravenous amiodarone and its electrocardiographic effects on healthy Japanese subjects. [2011.05]
A randomized active-controlled study comparing the efficacy and safety of vernakalant to amiodarone in recent-onset atrial fibrillation. [2011.01.18]
A randomized active-controlled study comparing the efficacy and safety of
vernakalant to amiodarone in recent-onset atrial fibrillation. [2011]
Metoprolol versus amiodarone in the prevention of atrial fibrillation after cardiac surgery: a randomized trial. [2010.12.07]
[A comparative study on the efficacy and safety of intravenous esmolol, amiodarone and diltiazem for controlling rapid ventricular rate of patients with atrial fibrillation during anesthesia period]. [2010.11]
The effect of amiodarone on cardiac rhythm after cardiopulmonary bypass in patients with atrial fibrillation. [2010.11]
Combination of irbesartan and amiodarone to maintain sinus rhythm in patients with persistent atrial fibrillation after rheumatic valve replacement. [2010.09]
A randomized, controlled study of amiodarone for prevention of atrial fibrillation after transthoracic esophagectomy. [2010.07]
A short-term, randomized, double-blind, parallel-group study to evaluate the efficacy and safety of dronedarone versus amiodarone in patients with persistent atrial fibrillation: the DIONYSOS study. [2010.06.01]
Effect of continuous versus episodic amiodarone treatment on quality of life in persistent atrial fibrillation. [2010.06]
Comparative study of nifekalant versus amiodarone for shock-resistant ventricular fibrillation in out-of-hospital cardiopulmonary arrest patients. [2010.04]
Amiodarone for the prevention of reperfusion ventricular fibrillation. [2010.04]
Perioperative intravenous amiodarone does not reduce the burden of atrial fibrillation in patients undergoing cardiac valvular surgery. [2010.01]
Combination of irbesartan and amiodarone to maintain sinus rhythm in patients with persistent atrial fibrillation after rheumatic valve replacement. [2010]
Low-dose amiodarone for the prevention of atrial fibrillation after coronary artery bypass grafting in patients older than 70 years. [2009.12.20]
Impact of implantable cardioverter-defibrillator, amiodarone, and placebo on the mode of death in stable patients with heart failure: analysis from the sudden cardiac death in heart failure trial. [2009.12.01]
Prophylactic amiodarone versus lidocaine for prevention of reperfusion ventricular fibrillation after release of aortic cross-clamp. [2009.12]
Evaluation of the effects of PM101, a cyclodextrin-based formulation of intravenous amiodarone, on blood pressure in healthy humans. [2009.10.15]
Postoperative oral amiodarone versus oral bisoprolol as prophylaxis against atrial fibrillation after coronary artery bypass graft surgery: a prospective randomized trial. [2009.10.02]
Biatrial pacing vs. intravenous amiodarone in prevention of atrial fibrillation after coronary artery bypass surgery. [2009.10.01]
Comparative efficacy of dronedarone and amiodarone for the maintenance of sinus rhythm in patients with atrial fibrillation. [2009.09.15]
A randomized trial evaluating amiodarone for prevention of atrial fibrillation after pulmonary resection. [2009.09]
The effects of intra-operative amiodarone loading on the systemic inflammatory response syndrome induced by cardiopulmonary bypass. [2009.08]
Intravenous diltiazem is superior to intravenous amiodarone or digoxin for achieving ventricular rate control in patients with acute uncomplicated atrial fibrillation. [2009.07]
[Comparison of amiodarone plus irbesartan regimen versus amiodarone alone on maintaining sinus rhythm in rheumatic heart disease patients with persistent atrial fibrillation post valve replacement and cardioversion] [2009.06]
[Therapeutic effects of amiodarone and metoprolol on chronic heart failure complicated by ventricular arrhythmia] [2009.06]
Bioequivalence of 2 intravenous amiodarone formulations in healthy participants. [2009.04]
Prevention of atrial fibrillation after coronary artery bypass grafting via atrial electromechanical interval and use of amiodarone prophylaxis. [2009.04]
Effect of single intraoperative dose of amiodarone in patients with rheumatic valvular heart disease and atrial fibrillation undergoing valve replacement surgery. [2009.01]
Ability of amiodarone and propranolol alone or in combination to prevent post-coronary bypass atrial fibrillation. [2009.01]
Continuous vs episodic prophylactic treatment with amiodarone for the prevention of atrial fibrillation: a randomized trial. [2008.10.15]
Quality of life with defibrillator therapy or amiodarone in heart failure. [2008.09.04]
[Clinical efficacy of irbesartan and amiodarone in elderly patients with paroxysmal atrial fibrillation.] [2008.09]
Combination therapy with amiodarone and enalapril in patients with paroxysmal atrial fibrillation prevents the development of structural atrial remodeling. [2008.07]
Amiodarone protects diabetics and non-diabetics undergoing coronary artery bypass grafting equally. [2008.06]
Amiodarone cost effectiveness in preventing atrial fibrillation after coronary artery bypass graft surgery. [2008.01]
Intravenous and oral administration of amiodarone for the treatment of recent onset atrial fibrillation after digoxin administration. [2007.10.18]
Thyroid function abnormalities during amiodarone therapy for persistent atrial fibrillation. [2007.10]
Comparative study of intravenous amiodarone and procainamide in the treatment of atrial fibrillation of recent onset. [2007.08]
A comparative study of the efficacy and safety of procainamide versus propafenone versus amiodarone for the conversion of recent-onset atrial fibrillation. [2007.06.15]
Conversion efficacy of intravenous ibutilide compared with intravenous amiodarone in patients with recent-onset atrial fibrillation and atrial flutter. [2007.06.12]
The safety of amiodarone in patients with heart failure. [2007.06]
Absence of bilateral vision loss from amiodarone: a randomized trial. [2007.05]
Amiodarone interacts with simvastatin but not with pravastatin disposition kinetics. [2007.05]
Role of amiodarone on the systemic inflammatory response induced by cardiac surgery: proinflammatory actions: [Role de l'amiodarone sur la reaction inflammatoire systemique provoquee par la chirurgie cardiaque : actions pro-inflammatoires]. [2007.04]
Practical regimen for amiodarone use in preventing postoperative atrial fibrillation. [2007.04]
Exercise capacity in atrial fibrillation: a substudy of the Sotalol-Amiodarone Atrial Fibrillation Efficacy Trial (SAFE-T). [2007.04]
[Comparison between therapeutic effects of acupuncture and intravenous injection of amiodarone in the treatment of paroxymal atrial fibrillation and atrial flutter] [2007.02]
Monophasic versus biphasic waveform shocks for atrial fibrillation cardioversion in patients with concomitant amiodarone therapy. [2007.02]
Comparative bioavailability study with two amiodarone tablet formulations administered with and without food in healthy subjects. [2007]
Long-term efficacy and safety of very-low-dose amiodarone treatment for the maintenance of sinus rhythm in patients with chronic atrial fibrillation after successful direct-current cardioversion. [2006.12.20]
Results from the Loire-Ardeche-Drome-Isere-Puy-de-Dome (LADIP) trial on atrial flutter, a multicentric prospective randomized study comparing amiodarone and radiofrequency ablation after the first episode of symptomatic atrial flutter. [2006.10.17]
Effect of low-dose amiodarone and magnesium combination on atrial fibrillation after coronary artery surgery. [2006.09]
High dose of amiodarone in a short-term period reduces the incidence of postoperative atrial fibrillation and atrial flutter. [2006.09]
Prospective randomized study comparing amiodarone vs. amiodarone plus losartan vs. amiodarone plus perindopril for the prevention of atrial fibrillation recurrence in patients with lone paroxysmal atrial fibrillation. [2006.08]
Effect of amiodarone and sotalol on ventricular defibrillation threshold: the optimal pharmacological therapy in cardioverter defibrillator patients (OPTIC) trial. [2006.07.11]
Amiodarone prophylaxis for atrial fibrillation of high-risk patients after coronary bypass grafting: a prospective, double-blinded, placebo-controlled, randomized study. [2006.07]
Effects of a high dose intravenous bolus amiodarone in patients with atrial fibrillation and a rapid ventricular rate. [2006.06.07]
Safety of amiodarone in the prevention of postoperative atrial fibrillation: a meta-analysis. [2006.05.01]
Design and rationale of a randomized study to compare amiodarone and Class IC anti-arrhythmic drugs in terms of atrial fibrillation treatment efficacy in patients paced for sinus node disease: the PITAGORA trial. [2006.04]
A randomized trial of prophylactic antiarrhythmic agents (amiodarone and sotalol) in patients with atrial fibrillation for whom direct current cardioversion is planned. [2006.04]
Japanese randomized trial for investigation of a combined therapy of amiodarone and implantable cardioverter defibrillator in patients with ventricular tachycardia and fibrillation: the Nippon ICD Plus Pharmachologic Option Necessity study design. [2006.03]
Comparison of beta-blockers, amiodarone plus beta-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: the OPTIC Study: a randomized trial. [2006.01.11]
Economic analysis of intravenous plus oral amiodarone, atrial septal pacing, and both strategies to prevent atrial fibrillation after open heart surgery. [2004.08]
Effect of right atrial pacing, intravenous amiodarone and beta blockers for suppression of atrial fibrillation after coronary artery bypass surgery: a pilot study. [2003.06]
Amiodarone reduces the incidence of atrial fibrillation after coronary artery bypass grafting. [2003.06]
Comparison of intravenous flecainide, propafenone, and amiodarone for conversion of acute atrial fibrillation to sinus rhythm. [2000.11.01]
Intravenous amiodarone for prevention of atrial fibrillation after coronary artery bypass grafting. [2000.07]
Intraoperative amiodarone as prophylaxis against atrial fibrillation after coronary operations. [2000.05]
Intravenous amiodarone for ventricular arrhythmias: overview and clinical use. [1998.10]
The efficacy and safety of intravenous propafenone versus intravenous amiodarone in the conversion of atrial fibrillation or flutter after cardiac surgery. [1996.02]
Intravenous amiodarone for recurrent sustained hypotensive ventricular tachyarrhythmias. Intravenous Amiodarone Multicenter Trial Group. [1996.01]
Intravenous amiodarone vs propafenone for atrial fibrillation and flutter after cardiac operation. [1995]
Intravenous amiodarone bolus versus oral quinidine for atrial flutter and fibrillation after cardiac operations. [1990.05]
Propafenone versus amiodarone in field treatment of primary atrial tachydysrhythmias. [1990.01]
Intravenous amiodarone in acute anterior myocardial infarction: a controlled study. [1989.01]
A randomized hemodynamic comparison of intravenous amiodarone with and without Tween 80. [1988.02]
Well-designed clinical trials possibly related to Amiodarone Injection
Estimation of potential cost savings associated with reduced rates of
cardiovascular hospitalization among atrial fibrillation/flutter patients treated
with dronedarone in the ATHENA trial. [2014]
A double-blind, randomized, controlled, multicenter study to assess the safety and cardiovascular effects of skeletal myoblast implantation by catheter delivery in patients with chronic heart failure after myocardial infarction. [2011.10]
n-3 polyunsaturated fatty acids in the prevention of atrial fibrillation recurrences after electrical cardioversion: a prospective, randomized study. [2011.09.06]
Clinical characteristics of patients with asymptomatic recurrences of atrial fibrillation in the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico-Atrial Fibrillation (GISSI-AF) trial. [2011.08]
Rhythm- and rate-controlling effects of dronedarone in patients with atrial fibrillation (from the ATHENA trial). [2011.04.01]
Efficacy of acupuncture in preventing atrial fibrillation recurrences after electrical cardioversion. [2011.03]
Final results of a phase IIa, randomised, open-label trial to evaluate the percutaneous intramyocardial transplantation of autologous skeletal myoblasts in congestive heart failure patients: the SEISMIC trial. [2011.02]
The efficacy of sotalol in preventing postoperative atrial fibrillation: a
meta-analysis. [2011]
n-3 polyunsaturated fatty acids in the prevention of atrial fibrillation
recurrences after electrical cardioversion: a prospective, randomized study. [2011]
Impact of dronedarone on hospitalization burden in patients with atrial
fibrillation: results from the ATHENA study. [2011]
Effect of dronedarone on exercise capacity and cardiac function in patients with severe left ventricular dysfunction and compensated stable heart failure. [2010.12]
Dronedarone therapy in atrial fibrillation: a summary of recent controlled trials. [2010.12]
Comparison of surgical cut and sew versus radiofrequency pulmonary veins isolation for chronic permanent atrial fibrillation: a randomized study. [2010.10]
Antiarrhythmic use from 1991 to 2007: insights from the Canadian Registry of Atrial Fibrillation (CARAF I and II). [2010.09]
The antiarrhythmic properties of quifenadine, H1-histamine receptor blocker in children with premature beats: a randomized controlled pilot trial. [2010.07]
Dronedarone in patients with congestive heart failure: insights from ATHENA. [2010.07]
Prevention of atrial fibrillation by Renin-Angiotensin system inhibition a meta-analysis. [2010.05.25]
Dronedarone Therapy in Atrial Fibrillation: A Summary of Recent Controlled Trials. [2010.05.14]
Clinical predictors of atrial fibrillation recurrence in the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico-Atrial Fibrillation (GISSI-AF) trial. [2010.05]
Physician stated atrial fibrillation management in light of treatment guidelines: data from an international, observational prospective survey. [2010.03]
The antiarrhythmic properties of quifenadine, H1-histamine receptor blocker in
children with premature beats: a randomized controlled pilot trial. [2010]
|
